BioMed Research International / 2022 / Article / Tab 4 / Research Article
[Retracted] Divergent Analyses of Genetic Relatedness and Evidence-Based Assessment of Therapeutics of Staphylococcus aureus from Semi-intensive Dairy Systems Table 4 Percentage efficacy of different treatment groups against S. aureus -based clinical mastitis.
(a)
Class of antibiotic Bacteriostatic with bacteriostatic ( ) Antibiotic with dose rate Alone Sulfadimidine Azithromycin Oxytetracycline Aminoglycoside Gentamicin (G) (2.2-6 mg/kg BW) 2/5 (40%) 3/5 (60%) 2/5 (40%) 4/5 (80%) Sulfonamide Sulfadimidine (45 mg/kg BW) IM 2/5 (40%) — 2/5 (40%) 3/5 (60%) Macrolide Azithromycin (A) (6-10 mg/kg BW) 1/5 (20%) — — 3/5 (60%) Tetracycline Oxytetracycline (O) (17 mg/kg BW) 4/5 (80%) — — —
(b)
Class of antibiotic Bactericidal with bactericidal ( ) Antibiotic with dose rate Alone Ciprofloxacin Vancomycin Cephalosporin Cefotaxime (Ce) (10 mg/kg BW) 3/5 (60%) 3/5 (60%) 4/5 (80%) Fluoroquinolones Ciprofloxacin (Ci) (5-10 mg/kg body weight) (IV) 3/5 (60%) — 4/5 (80%) Glycopeptides Vancomycin (V) (8-12 mg/kg BW) (IV) 3/5 (60%) — —